Publications by authors named "M Bagher Shiran"

Multiple sclerosis (MS) is an inflammatory neurodegenerative disorder characterized by demyelination. Lutein, a xanthophyll carotenoid, has well-known antioxidant and anti-inflammatory properties. In this experiment, we aimed to investigate the neuroprotective and remyelination potential of lutein in comparison with dimethyl fumarate (DMF) as a reference drug in post-cuprizone-intoxicated C57BL/6 mice.

View Article and Find Full Text PDF

Objectives: Neurodegenerative diseases are defined by specific protein accumulation and anatomic vulnerability leading to neuronal loss. Some studies have shown that lutein may have an effect on neurodegenerative diseases. As most of the neurodegenerative diseases don't have certain cure and therapies focus on symptom control, Lutein may be a complementary treatment.

View Article and Find Full Text PDF

In the human brain, the regions responsible for emotion processing, motivation, and memory are heavily influenced by olfaction, whose neural pathway is directly exposed to the outer world. In this study, we used fMRI to examine how different olfactory conditions might affect the functional connectivity circuit underlying working memory in the brain. To this end, 30 adults (aged 20-35), 13 males and 17 females, with high educational levels were chosen.

View Article and Find Full Text PDF

Background And Purpose: Olfaction is an early marker of neurodegenerative disease. Standard olfactory function is essential due to the importance of olfaction in human life. The psychophysical evaluation assesses the olfactory function commonly.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines how the CYP2D6 gene polymorphism influences breast cancer patients' responses to tamoxifen (TAM) treatment, noting interindividual variability in therapeutic outcomes.
  • - Researchers analyzed blood samples to measure TAM and its metabolites using HPLC-FLU and identified specific CYP2D6 genetic variants in a group of Iranian women with breast cancer.
  • - Results indicated that while poor or intermediate metabolizers had lower plasma concentrations of tamoxifen metabolites compared to extensive metabolizers, the differences were not statistically significant, highlighting the complexity of individual responses to treatment.
View Article and Find Full Text PDF